Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer

Conclusions: Our study revealed that a PIRDEG signature could be a candidate prognostic biomarker for predicting the overall survival (OS) of patients with BRCA.
Source: Frontiers in Genetics - Category: Genetics & Stem Cells Source Type: research